Mitomycin Approved for Low-Grade Upper Tract Urothelial Cancer Mitomycin Approved for Low-Grade Upper Tract Urothelial Cancer
The Food and Drug Administration has approved mitomycin, the first therapy for adults with low-grade upper tract urothelial cancer.FDA Approvals
Source: Medscape Urology Headlines - Category: Urology & Nephrology Tags: Hematology-Oncology News Alert Source Type: news
More News: Cancer | Cancer & Oncology | Food and Drug Administration (FDA) | Hematology | Urology & Nephrology